• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.15% Nasdaq Up 0.36%

    ImmunoGen, Inc. (IMGN)

    -NasdaqGS
    6.11 Down 4.74(43.69%) Dec 19, 4:00PM EST
    |After Hours : 6.00 Down 0.11 (1.80%) Dec 19, 7:59PM EST
    Add to Portfolio
    Prev Close:10.85
    Open:5.97
    Bid:N/A
    Ask:6.17 x 2000
    1y Target Est:12.41
    Beta:1.84
    Next Earnings Date:30-Jan-15IMGN Earnings announcement
    Day's Range:5.36 - 6.82
    52wk Range:5.36 - 17.80
    Volume:16,592,698
    Avg Vol (3m):1,519,870
    Market Cap:525.06M
    P/E (ttm):N/A
    EPS (ttm):-0.96
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Related Video

    Headlines

    » More Headlines for IMGN

    Comparison

    Symbol% ChgMkt Cap
    IMGNDown 43.69%525.06M
    PFEDown 0.09%201.24B
    RHHBYDown 6.59%234.22B
    SGENDown 0.45%4.07B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):16.69
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Jun-15) :-0.67
    Quarterly EPS Est (Dec-14) :-0.05
    Mean Recommendation*:2.7
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    ImmunoGen, Inc., a biotechnology company, develops targeted anticancer therapeutics. It develops its products using its antibody-drug conjugates technology. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback